By Christine Kilgore, Medscape
Advancing remedy for what has been variably known as continual Lyme and posttreatment Lyme disease (PTLD) is underneath the eyes of a Nationwide Academies of Science, Engineering, and Medication (NASEM) committee of consultants for the primary time — a 12 months after the NASEM shone a highlight on the necessity to speed up analysis on continual sicknesses that comply with identified or suspected infections.
The committee is not going to make suggestions on particular approaches to prognosis and remedy when it points a report in early 2025 however will as a substitute current “consensus findings” on remedy for continual sickness related to Lyme disease, together with suggestions for advancing remedy. READ MORE
